Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xeris Biopharma Holdings, Inc. XERS

Set alert

Price alert · XERS

All alert types
10.42 USD +0.25 +2.46%

As of Nov 3, 10:31 AM ET

Bid
10.39 × 2
Ask
10.40 × 2
10.17 Day range 10.56
5.25 52-week range 11.42
YTD
+32.74%
1 year
+5.25%
Open
10.17
Prev close
10.17
Mkt cap
1.90B
Vol
286.98K
Avg vol
2.35M
EPS
-0.10
P/E
0.00
Div yield
0.00%
More statistics
Low
10.17
High
10.56
Forward P/E
51.71
Beta
0.84
Short ratio
2.46
Inst. own
61.87%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
9.31
200-d avg
7.50
1y target
12.86

5D chart

Chart tools
Interval
1m5m15m30m

Signals (88)
NameTimeAgo
SMA: BearishNov 3, 10:15 AM16 minutes ago
SMA: BullishNov 3, 10:10 AM21 minutes ago
SMA: BearishNov 3, 10:05 AM26 minutes ago
SMA: BullishNov 3, 9:30 AM1 hour ago
SMA: BullishNov 3, 9:30 AM1 hour ago
MACD: Buy SignalNov 3, 9:30 AM1 hour ago
RSI: OverboughtNov 3, 9:30 AM1 hour ago
SMA: BearishNov 2, 3:55 PM18 hours ago
MACD: Sell SignalNov 2, 3:55 PM18 hours ago
SMA: BearishNov 2, 3:50 PM18 hours ago
SMA: BullishNov 2, 2:40 PM19 hours ago
MACD: Buy SignalNov 2, 2:10 PM20 hours ago
SMA: BearishNov 2, 1:10 PM21 hours ago
MACD: Sell SignalNov 2, 1:10 PM21 hours ago
SMA: BearishNov 2, 1:00 PM21 hours ago
SMA: BullishNov 2, 11:50 AM22 hours ago
SMA: BullishNov 2, 11:05 AM23 hours ago
MACD: Buy SignalNov 2, 11:05 AM23 hours ago
SMA: BearishNov 2, 10:50 AM23 hours ago
SMA: BullishNov 2, 10:45 AM23 hours ago

Newest 20 of 88.

Analyst view

Consensus: none

Price target (mean) 12.86 +23.4% upside
Target (low)
8.00
Target (mean)
12.86
Target (high)
18.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

XERS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.026670.01 – 0.040.000.0%101.68M+36.7%3
Next quarter0.033330.00 – 0.060.06-44.5%111.02M+29.4%3
Current year-0.09-0.14 – -0.030.000.0%387.90M+32.9%3
Next year0.196670.11 – 0.25-0.09+318.5%480.03M+23.8%3

Upgrades and downgrades

The latest rating changes

XERS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 6, 2026BarclaysMaintainedOverweightOverweight
Sep 10, 2026Leerink PartnersMaintainedOutperformOutperform
Aug 20, 2026BarclaysMaintainedOverweightOverweight
Mar 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 9, 2026HC Wainwright & Co.ReiteratedBuyBuy
Dec 9, 2025BarclaysInitiated—Overweight
Nov 7, 2025OppenheimerMaintainedOutperformOutperform
Nov 7, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 7, 2025Piper SandlerMaintainedNeutralNeutral
Oct 29, 2025OppenheimerMaintainedOutperformOutperform
Sep 17, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 19, 2025Leerink PartnersMaintainedOutperformOutperform
Aug 8, 2025Craig-HallumMaintainedBuyBuy
Aug 8, 2025OppenheimerMaintainedOutperformOutperform
Jun 5, 2025Leerink PartnersMaintainedOutperformOutperform
May 9, 2025OppenheimerMaintainedOutperformOutperform
Mar 7, 2025Piper SandlerReiteratedNeutralNeutral
Mar 7, 2025Leerink PartnersMaintainedOutperformOutperform
Mar 7, 2025Craig-HallumMaintainedBuyBuy
Mar 7, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 29, 2025JefferiesReiteratedBuyBuy
Nov 11, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 11, 2024Piper SandlerDowngradeOverweightNeutral
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024Piper SandlerReiteratedOverweightOverweight
Mar 28, 2024OppenheimerInitiated—Outperform
Mar 7, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 10, 2023Piper SandlerMaintainedOverweightOverweight